Key result
High-dose intravenous dexmedetomidine infusion was associated with the development of polyuria in a 59-year-old man in the medical intensive care unit.
Case Report (n=1)
Highlights a rare case of polyuria as an adverse effect of high-dose dexmedetomidine infusion in the intensive care unit.
Dexmedetomidine is an α2 agonist that is frequently used for sedation in intensive care units (ICUs). Hypotension and bradycardia are common adverse effects observed in clinical practice. In perioperative conditions, polyuria is a rare adverse effect with limited case reports after dexmedetomidine infusion. Similar to this situation, in ICU, there are rare cases. We present the case of a 59-year-old man who developed polyuria secondary to high-dose intravenous dexmedetomidine infusion in the medical ICU.
No takes yet. Share an insight, caveat, or question.
Nurcan Kutluer Karaca (2022) conducted a case report in Polyuria (n=1). Dexmedetomidine was evaluated on Polyuria. High-dose intravenous dexmedetomidine infusion was associated with the development of polyuria in a 59-year-old man in the medical intensive care unit.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: